Form 4 for WST West Pharmaceutical Services
Accepted 2026-02-23 00:00:00 ET · period of report 2026-02-20 · accession 0000105770-26-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-23 | 2026-02-20 | WST | Witherspoon Charles | VP, Treas | F - Tax | $241.12 | -22.07 | 1,408 | -2% | -$5,322 |
| D | 2026-02-23 | 2026-02-20 | WST | Witherspoon Charles | VP, Treas | M - OptEx | — | +60.22 | 1,430 | +4% | — |
| D | 2026-02-23 | 2026-02-20 | WST | Witherspoon Charles | VP, Treas | M - OptEx | $0.00 | -60.22 | 177.64 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-20 | F | D | 22.07 | $241.12 | 1,407.90 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-20 | M | A | 60.22 | — | 1,429.97 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Derivative | Rst. Stock Unit | 2026-02-20 | M | D | 60.22 | $0.00 | 177.64 | D | — · — to — | 60.22 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On February 18, 2025, the reporting person was granted 237 restricted stock units, vesting in four equal annual installments (plus dividend equivalents) on February 20th each year. |